Immunome Inc expected to post a loss of 69  cents a share - Earnings Preview

Immunome

07/05/2022 02:39

* Immunome Inc  IMNM.OQ   IMNM.O  is expected to report
results on
May 10 (estimated).
    * ​Refinitiv's mean analyst estimate for Immunome Inc is for
a
loss of 69 cents per share. For the same quarter last year, the
company reported a loss of 37 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Immunome
Inc is
$15​, above​ its last closing price of $3.10. ​​​

This summary was machine generated May 7 at 01:39 GMT.  All
figures in US dollars  unless otherwise stated